Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity

References

• Attanoos R, Williams GT. Epithelial and neuroendocrine tumors of the duodenum. Semin Diagn Pathol. 1991;8:149–162.
   PubMed Web of Science ®Google Scholar
• Jensen RT, Rindi G, Arnold R, et al. Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology. 2006;84:165–172.
   PubMed Web of Science ®Google Scholar
• O’Toole D, Delle Fave G, Jensen RT. Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26:719–735.
   PubMed Web of Science ®Google Scholar
• Dogeas E, Cameron JL, Wolfgang CL, et al. Duodenal and ampullary carcinoid tumors: size predicts necessity for lymphadenectomy. J Gastrointest Surg. 2017;21:1262–1269.
   PubMed Web of Science ®Google Scholar
• Fitzgerald TL, Dennis SO, Kachare SD, et al. Increasing incidence of duodenal neuroendocrine tumors: incidental discovery of indolent disease? Surgery. 2015;158:466–471.
   PubMed Web of Science ®Google Scholar
• Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072.
   PubMed Web of Science ®Google Scholar
• Lipinski M, Rydzewska G, Foltyn W, et al. Gastroduodenal neuroendocrine neoplasms including gastrinoma – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2017;68:138–153.
   PubMed Web of Science ®Google Scholar
• Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13–27.
   PubMed Web of Science ®Google Scholar
• Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: classification functional syndromes diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005;19:675–697.
   PubMed Web of Science ®Google Scholar
• Hatzitheoklitos E, Büchler MW, Friess H, et al. Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer. 1994;73:1580–1588.
   PubMed Web of Science ®Google Scholar
• Walton GF, Gibbs ER, Spencer GO, et al. Carcinoid tumors of the ampulla of Vater. Am Surg. 1997;63:302–304.
   PubMed Web of Science ®Google Scholar
• Bornstein-Quevedo L, Gamboa DA. Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic immuno-histochemical and cell kinetic comparison. Hum Pathol. 2001;32:1252–1256.
   PubMed Web of Science ®Google Scholar
• Clements WM, Martin SP, Stemmerman G, et al. Ampullary carcinoid tumors: rationale for an aggressive surgical approach. J Gastrointest Surg. 2003;7:773–776.
   PubMed Web of Science ®Google Scholar
• Hartel M, Wente MN, Sido B, et al. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol. 2005;20:676–681.
   PubMed Web of Science ®Google Scholar
• Witzigmann H, Loracher C, Geissler F, et al. Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy. Langenbecks Arch Surg. 2002;386:525–533.
   PubMed Web of Science ®Google Scholar
• Delle Fave G, O’Toole D, Sundin A, et al. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology. 2016;103:119–124.
   PubMed Web of Science ®Google Scholar
• Plockinger U. Diagnosis and treatment of gastrinomas in multiple endocrine neoplasia type 1 (MEN-1). Cancers (Basel). 2012;4:39–54.
   PubMedGoogle Scholar
• Gibril F, Schumann M, Pace A, et al. Multiple endocrine neoplasia type 1 and Zollinger–Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore). 2004;83:43–83.
   PubMed Web of Science ®Google Scholar
• Jensen RT. Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med. 1998;243:477–488.
   PubMed Web of Science ®Google Scholar
• Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger–Ellison syndrome. N Engl J Med. 1999;341:635–644.
   PubMed Web of Science ®Google Scholar
• Ellison EC, Johnson JA. The Zollinger–Ellison syndrome: a comprehensive review of historical scientific and clinical considerations. Curr Probl Surg. 2009;46:13–106.
   PubMed Web of Science ®Google Scholar
• Jensen RT, Niederle B, Mitry E, et al. Gastrinoma (duodenal and pancreatic). Neuroendocrinology. 2006;84:173–182.
   PubMed Web of Science ®Google Scholar
• Jensen RT, Cadiot G, Brandi ML, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98–119.
   PubMed Web of Science ®Google Scholar
• Yoshikane H, Suzuki T, Yoshioka N, et al. Duodenal carcinoid tumor: endosonographic imaging and endoscopic resection. Am J Gastroenterol. 1995;90:642–644.
   PubMed Web of Science ®Google Scholar
• Zimmer T, Stolzel U, Bader M, et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut. 1996;39:562–568.
   PubMed Web of Science ®Google Scholar
• Khan RN, Bansal VK, Kumar S, et al. Duodenal gastrinoma: a diagnostic dilemma. Am J Surg. 2009;197:e48–e50.
   PubMedGoogle Scholar
• Acs G, McGrath CM, Gupta PK. Duodenal carcinoid tumor: report of a case diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy with immuno-cytochemical correlation. Diagn Cytopathol. 2000;23:183–186.
   PubMed Web of Science ®Google Scholar
• Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005;103:1587–1595.
   PubMed Web of Science ®Google Scholar
• Bordi C. Gastric carcinoids. Ital J Gastroenterol Hepatol. 1999;31:S94–S97.
   PubMed Web of Science ®Google Scholar
• Gough DB, Thompson GB, Crotty TB, et al. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg. 1994;18:473–479.
   PubMed Web of Science ®Google Scholar
• Dalenback J, Havel G. Local endoscopic removal of duodenal carcinoid tumors. Endoscopy. 2004;36:651–655.
   PubMed Web of Science ®Google Scholar
• Ichikawa J, Tanabe S, Koizumi W, et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy. 2003;35:203–206.
   PubMed Web of Science ®Google Scholar
• Lebtahi R, Cadiot G, Delahaye N, et al. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med. 1999;40:1602–1608.
   PubMed Web of Science ®Google Scholar
• Rindi G, Arnold R, Bosman FT, et al., editors. WHO classification of tumors of the digestive system. Lyon: IRAC; 2010. p. 13–14.
   Google Scholar
• Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al. ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95:74–87.
   PubMed Web of Science ®Google Scholar
• Vanoli A, La Rosa S, Klersy C, et al. Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: analysis of 203 cases. Neuroendocrinology. 2017;104:112–125.
   PubMed Web of Science ®Google Scholar
• Burke AP, Sobin LH, Federspiel BH, et al. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med. 1990;114:700–704.
   PubMed Web of Science ®Google Scholar
• Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer. 1999;85:1241–1249.
   PubMed Web of Science ®Google Scholar
• Hatta W, Koike T, Iijima K, et al. The risk factors for metastasis in non-ampullary duodenal neuroendocrine tumors measuring 20 mm or less in diameter. Digestion. 2017;95:201–209.
   PubMed Web of Science ®Google Scholar
• Carter JT, Grenert JP, Rubenstein L, et al. Neuroendocrine tumors of the ampulla of Vater: biological behavior and surgical management. Arch Surg. 2009;144:527–531.
   PubMedGoogle Scholar
• Anthony T, Kim L. Gastrointestinal carcinoid tumors and the carcinoid syndrome. In: Feldman M, Friedman L, Sleisenger M, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease. 7th ed. Philadelphia: Saunders; 2002. p. 2151–2168.
   Google Scholar
• Pavel M, de Herder WW. ENETS consensus guidelines for the standard of care in neuroendocrine tumors. Neuroendocrinology. 2017;105:193–195.
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Miyatani H, Yoshida Y, et al. Duodenal carcinoid tumors: 5 cases treated by endoscopic submucosal dissection. Gastrointest Endosc. 2011;74:1152–1156.
   PubMed Web of Science ®Google Scholar
• Honda T, Yamamoto H, Osawa H, et al. Endoscopic submucosal dissection for superficial duodenal neoplasms. Dig Endosc. 2009;21:270–274.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Ishii N, Uemura M, et al. Endoscopic submucosal dissection (ESD) for gastrointestinal carcinoid tumors. Surg Endosc. 2012;26:759–763.
   PubMed Web of Science ®Google Scholar
• Osera S, Oono Y, Ikematsu H, et al. Endoscopic submucosal resection with a ligation device for the treatment of duodenal neuroendocrine tumors. Surg Endosc. 2016;30:3928–3932.
   PubMed Web of Science ®Google Scholar
• Kim GH, Kim JI, Jeon SW, et al. Endoscopic resection for duodenal carcinoid tumors: a multicenter retrospective study. J Gastroenterol Hepatol. 2014;29:318–324.
   PubMed Web of Science ®Google Scholar
• Alexander S, Bourke MJ, Williams SJ, et al. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Gastrointest Endosc. 2009;69:66–73.
   PubMed Web of Science ®Google Scholar
• Min YW, Min BH, Kim ER, et al. Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas. Dig Dis Sci. 2013;58:2926–2932.
   PubMed Web of Science ®Google Scholar
• Basford PJ, George R, Nixon E, et al. Endoscopic resection of sporadic duodenal adenomas: comparison of endoscopic mucosal resection (EMR) with hybrid endoscopic submucosal dissection (ESD) techniques and the risks of late delayed bleeding. Surg Endosc. 2014;28:1594–1600.
   PubMed Web of Science ®Google Scholar
• Sohn JW, Jeon SW, Cho CM, et al. Endoscopic resection of duodenal neoplasms: a single-center study. Surg Endosc. 2010;24:3195–3200.
   PubMed Web of Science ®Google Scholar
• Patel R, Varadarajulu S, Wilcox CM. Endoscopic ampullectomy: techniques and outcomes. J Clin Gastroenterol. 2012;46:8–15.
   PubMed Web of Science ®Google Scholar
• Kumta NA, Desai A, Doshi R, et al. Endoscopic mucosal resection of duodenal carcinoid. Endoscopy. 2016;Suppl.1:E158–E159.
   Google Scholar
• Clark OH, Benson AB, 3rd, Berlin JD, et al. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw. 2009;7:712–747.
   PubMed Web of Science ®Google Scholar
• Baumann T, Rottenburger C, Nicolas G, et al. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) – imaging and staging. Best Pract Res Clin Endocrinol Metab. 2016;30:45–57.
   PubMed Web of Science ®Google Scholar
• Iwasaki T, Nara S, Kishi Y, et al. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Langenbecks Arch Surg. 2017;402:925–933.
   PubMed Web of Science ®Google Scholar
• Ichikawa D, Komatsu S, Dohi O, et al. Laparoscopic and endoscopic co-operative surgery for non-ampullary duodenal tumors. WJG. 2016;22:10424–10431.
   PubMed Web of Science ®Google Scholar
• Winter JM, Cameron JL, Olino K, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg. 2010;14:379–387.
   PubMed Web of Science ®Google Scholar
• Downs-Canner S, Van der Vliet WJ, Thoolen SJ, et al. Robotic surgery for benign duodenal tumors. J Gastrointest Surg. 2015;19:306–312.
   PubMed Web of Science ®Google Scholar
• Soga J. Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res. 2003;22:349–363.
   PubMed Web of Science ®Google Scholar
• Untch BR, Bonner KP, Roggin KK, et al. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg. 2014;18:457–462.
   PubMed Web of Science ®Google Scholar
• Rinke A, Müller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group. JCO. 2009;27:4656–4663.
   PubMed Web of Science ®Google Scholar
• Caplin ME, Pavel M, Ćwikła JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224–233.
   PubMed Web of Science ®Google Scholar
• Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177 Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125–135.
   PubMed Web of Science ®Google Scholar